Drugs / [11C]AZ10419369
last change Oct 2010 re-read 2 minutes ago

[11C]AZ10419369

Investigated by
AstraZeneca

Trials 1 · a red edge is where a trial was stopped

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01085123 May → Oct 2010 migraine disorder AstraZeneca Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as [11C]AZ10419369 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01085123
Route Intravenous “solution for iv injection” NCT01085123